Related Experiment Video
Updated: Aug 8, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
Pulmonary Non-tuberculous Mycobacterial Infections in Category II Failures from National Tuberculosis Programme
Pulmonary non-tuberculous mycobacteria (NTM) infections are rising and can mimic tuberculosis. Prolonged treatment is crucial for cure, as early discontinuation in immune-competent individuals led to recurrence and altered drug susceptibility.
Area of Science:
- Pulmonology
- Infectious Diseases
- Microbiology
Background:
- Non-tuberculous mycobacteria (NTM) pulmonary infections are increasingly diagnosed.
- These infections can present similarly to drug-resistant tuberculosis, complicating diagnosis.
- Current treatment guidelines for NTM infections are lacking regarding drug combinations and duration.
Observation:
- Two cases of pulmonary NTM infection in immunocompetent individuals were reported.
- Patients showed good initial response to treatment, including bacteriological, radiological, and clinical improvements.
- Early cessation of treatment in both cases resulted in disease recurrence.
Findings:
- Recurrence of NTM infection was observed after early treatment discontinuation.
- Altered drug susceptibility patterns were noted upon recurrence.
- These findings highlight the challenges in achieving a definitive cure for NTM pulmonary infections.
Implications:
- The study suggests that prolonged treatment duration is necessary for achieving a cure in pulmonary NTM infections, even in immunocompetent hosts.
- Clinical suspicion and repeated microbiological confirmation are vital for accurate diagnosis.
- Further research is needed to establish definitive treatment guidelines, including optimal drug regimens and treatment duration for NTM infections.
More Related Videos
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis